ALXO Q3 2020 Earnings — ALX Oncology Holdings Inc. Revenue & Financial Results | Market Cap Arena

ALXOALX Oncology Holdings Inc.

$113M

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$10M

Net Income

-$10M

EPS (Diluted)

$-0.34

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$689,000

Balance Sheet

Total Assets

$262M

Total Liabilities

$10M

Stockholders' Equity

$252M

Cash & Equivalents

$259M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$1M	-100.0%
Gross Profit	$0	$114,000	-100.0%
Operating Income	-$10M	-$3M	-223.3%
Net Income	-$10M	-$3M	-234.5%